...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors.
【24h】

Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors.

机译:第5天早上血清皮质醇可预测经蝶窦手术后垂体肿瘤的下丘脑-垂体-肾上腺功能。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Adrenal insufficiency is a complication of transsphenoidal surgery (TSS) for pituitary adenoma, and correct identification of patients requiring glucocorticoid replacement is important. Controversy exists over which early postoperative 9 AM cortisol concentration reliably predicts hypothalamic-pituitary-adrenal (HPA) axis reserve, as defined by the insulin tolerance test (ITT). METHODS: Data were reviewed for 36 patients undergoing TSS followed by day 5 postoperative 9 AM cortisol measurement and ITT 6 weeks postsurgery. All patients received postoperative glucocorticoid replacement, which was discontinued if the 9 AM serum cortisol was >300 nmol/L. RESULTS: Of 23 patients who failed the ITT (peak cortisol <500 nmol/L), 20 also had a day 5, 9 AM serum cortisol <300 nmol/L. Nine of 13 patients who passed the ITT had a day 5, 9 AM cortisol >300 nmol/L. The cutoff cortisol concentration of 300 nmol/L had 86.9% (66.4%-97.2%) diagnostic sensitivity, 69.2% (38.6%-90.9%) diagnostic specificity, and 83.3% (61.8%-94.5%) positive predictive value (PPV) for detecting secondary adrenal insufficiency. Increasing the cutoff to 392 nmol/L resulted in 100% (85.2%-100%) sensitivity, 46.1% (19.2%-74.9%) specificity, and 76.6% (57.3%-89.4%) PPV. Decreasing the cutoff to 111 nmol/L resulted in 100% (75.3%-100%) specificity and 100% (67.9%-100%) PPV, although sensitivity was 47.8% (26.8%-69.4%). CONCLUSIONS: A day 5 post-TSS 9 AM serum cortisol <111 nmol/L reliably detects secondary adrenal insufficiency, and concentrations >392 nmol/L support intact HPA function. Because concentrations of 111-392 nmol/L are poorly predictive of HPA function, glucocorticoid replacement should continue in such cases until definitive testing is performed using an ITT.
机译:背景:肾上腺皮质功能不全是经蝶窦手术(TSS)治疗垂体腺瘤的并发症,正确识别需要糖皮质激素替代的患者非常重要。根据胰岛素耐受性测试(ITT)的定义,术后早期9 AM皮质醇浓度能否可靠地预测下丘脑-垂体-肾上腺(HPA)轴储备存在争议。方法:回顾性分析了36例接受TSS,随后在术后第5天,上午9点测量皮质醇和术后6周进行ITT的患者的数据。所有患者术后均接受糖皮质激素替代治疗,如果上午9点血清皮质醇> 300 nmol / L,则停用该药物。结果:在23例ITT失败(峰值皮质醇<500 nmol / L)的患者中,有20名患者在第5天,上午9点血清皮质醇<300 nmol / L。通过ITT的13例患者中有9例在第5天,上午9点皮质醇> 300 nmol / L。临界皮质醇浓度为300 nmol / L具有86.9%(66.4%-97.2%)的诊断敏感性,69.2%(38.6%-90.9%)的诊断特异性和83.3%(61.8%-94.5%)的阳性预测值(PPV)用于检测继发性肾上腺功能不全。将临界值提高到392 nmol / L可获得100%(85.2%-100%)的敏感性,46.1%(19.2%-74.9%)的特异性和76.6%(57.3%-89.4%)的PPV。将临界值降低至111 nmol / L可获得100%(75.3%-100%)的特异性和100%(67.9%-100%)的PPV,尽管灵敏度为47.8%(26.8%-69.4%)。结论:TSS 9 AM后第5天,血清皮质醇<111 nmol / L可以可靠地检测到继发性肾上腺功能不全,并且浓度> 392 nmol / L可以支持完整的HPA功能。由于111-392 nmol / L的浓度不能很好地预测HPA功能,因此在这种情况下应继续使用糖皮质激素替代治疗,直到使用ITT进行确诊为止。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号